
When two-year-old Josephine was diagnosed with a rare brain cancer, her father switched focus, hoping he could do something about it.
Originally a pediatric leukaemia research specialist, Matt Dun began researching diffuse intrinsic pontine glioma (DIPG) in 2018 after he found out the only therapy available to his daughter was palliative radiation.